Alembic Pharmaceuticals Limited (BOM:533573)
935.05
-15.15 (-1.59%)
At close: Aug 8, 2025
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 184.02 billion as of August 8, 2025. Its market cap has decreased by -20.35% in one year.
Market Cap
184.02B
Enterprise Value
195.75B
Revenue
68.21B
Ranking
n/a
PE Ratio
30.51
Stock Price
935.05
Market Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 184.02B, an increase of 1,944.32%. That is a compound annual growth rate of 24.27%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 184.02B | -12.20% |
Dec 31, 2024 | 209.59B | 40.41% |
Dec 29, 2023 | 149.27B | 32.55% |
Dec 30, 2022 | 112.61B | -28.56% |
Dec 31, 2021 | 157.62B | -22.43% |
Dec 31, 2020 | 203.20B | 88.67% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Reliance Industries | 17.65T |
HDFC Bank | 15.31T |
Bharti Airtel | 11.54T |
Tata Consultancy Services | 11.02T |
ICICI Bank | 10.28T |
State Bank of India | 7,432.66B |
Infosys | 5,956.20B |
Hindustan Unilever | 5,915.10B |